MONDAY, June 6, 2022 (HealthDay News) — A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are full. It may be asContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimabContinue Reading
MONDAY, June 6, 2022 (American Heart Association News) — Brian Kennedy was living his dream. A piano prodigy, he moved from his hometown of Kansas City, Missouri, to Los Angeles in 2003, when he was 20. He started out as a musician for hire, playing a handful of instruments andContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Two “smart bomb” drugs are offering new hope to women with aggressive breast cancers, a pair of clinical trials show. Both medications are antibody-drug conjugates, consisting of a chemo drug that’s been wedded to an antibody that delivers the chemotherapy directly to cancerContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Diabetes increases the odds that a COVID-19 infection will be severe, and folks with diabetes may be up to four times more likely to develop long-lasting symptoms, new research suggests. “Though more data is needed, some early studies suggest that diabetes may beContinue Reading
New treatments may battle advanced breast cancers. Two “smart bomb” drugs are offering new hope to women with aggressive breast cancers, a pair of clinical trials show. Read more People with diabetes have 4 times the odds for long COVID. Symptoms may come and go or persist, and they canContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — New research points to a compelling interplay between inflammatory bowel disease (IBD) and depression. IBD includes Crohn’s disease and ulcerative colitis. In addition to the physical pain that these illnesses can inflict upon sufferers, the new study showed that patients face a significantlyContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Production has resumed at the Michigan infant formula plant forced to close in February over product contamination and safety lapses, but it will take about three weeks before new formula from the plant makes its way to American consumers, Abbott Nutrition said Saturday.Continue Reading
MONDAY, June 6, 2022 (HealthDay News) — Here’s a simple weapon to employ against the opioid epidemic: New research finds that placing time limits on prescriptions for highly addictive narcotic painkillers may reduce the risk of misuse. In 2019, 1% of opioid prescriptions from U.S. dentists and surgeons were filledContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Holocaust survivors have a lower risk of delirium after surgery than others their age, and a new study suggests it may owe to mental resilience developed in response to their horrific experiences. “Given that Holocaust survivors are at increased risk of a rangeContinue Reading